{"answers":{"affected":"It affects 1 product.","exploited":"There is no known exploitation of CVE-2011-3386 in the wild and no public exploit code.","fix":"No fix has been published for CVE-2011-3386 yet. Limit exposure of the affected software until one is available.","what":"CVE-2011-3386 is a medium-severity missing authorization vulnerability in n/a, published on 2 Sep 2011. It can only be exploited from the same machine or local network, with no action from the victim."},"fix_prompt":"Check this codebase for CVE-2011-3386 and fix it if it is affected.\n\nWhat it is: CVE-2011-3386 is a medium-severity missing authorization vulnerability in n/a, published on 2 Sep 2011. It can only be exploited from the same machine or local network, with no action from the victim.\nExploitation: There is no known exploitation of CVE-2011-3386 in the wild and no public exploit code.\n\nAffected product: n/a. No package-level version data is available, so check the vendor advisory linked from the reference page.\n\nTask:\n1. Search the dependency manifests and lockfiles (for example package.json, package-lock.json, requirements.txt, poetry.lock, uv.lock, pom.xml, build.gradle, go.mod, Cargo.lock, Gemfile.lock) and any Dockerfiles for the affected packages, including transitive dependencies.\n2. If an affected version is in use, upgrade it to the fixed version for its release line with the project's package manager, so the lockfile is regenerated. Prefer the smallest upgrade that fixes it.\n3. If there is no fix, or the upgrade would break the build, do not guess: explain the risk and the safest workaround instead.\n4. Run the tests and summarise what changed and why.\n5. If nothing in the project is affected, say so and change nothing.\n\nReference: https://insights.sbomify.com/CVE-2011-3386/ (Markdown: https://insights.sbomify.com/CVE-2011-3386/index.md)","id":"CVE-2011-3386","markdown":"https://insights.sbomify.com/CVE-2011-3386/index.md","name":"CVE-2011-3386","record":{"aliases":["GHSA-9w6r-m8w5-8xw6"],"analysis":{"component_type":"iot_embedded","fix_type":"no_fix_stated","impacts":["data_modify","denial_of_service"],"network_reachable":"adjacent_or_local","non_default_config":false,"product_category":"wireless insulin pump","requires_auth":"none","summary":"Remote attackers can modify insulin delivery and cause denial of service via wireless communications using the device serial number.","user_interaction":"not_required","vuln_class":"missing_authorization"},"analysis_generated_by":"qwen3.8-flash-next","assigner":"mitre","cpe":[{"product":"paradigm_wireless_insulin_pump","vendor":"medtronic"}],"cvss":{"score":4,"severity":"medium","source":"nvd","vector":"AV:N/AC:H/Au:N/C:N/I:P/A:P","version":"2.0"},"cwes":[],"description":"Unspecified vulnerability in Medtronic Paradigm wireless insulin pump 512, 522, 712, and 722 allows remote attackers to modify the delivery of an insulin bolus dose and cause a denial of service (adverse human health effects) via unspecified vectors involving wireless communications and knowledge of the device's serial number, as demonstrated by Jerome Radcliffe at the Black Hat USA conference in August 2011.  NOTE: the vendor has disputed the severity of this issue, saying \"we believe the risk of deliberate, malicious, or unauthorized manipulation of medical devices is extremely low... we strongly believe it would be extremely difficult for a third-party to wirelessly tamper with your insulin pump... you would be able to detect tones on the insulin pump that weren't intentionally programmed and could intervene accordingly.\"","ecosystems":[],"exploits":{"exploitdb":0,"first_seen":null,"github_poc":0,"max_poc_stars":null,"metasploit":0,"nuclei":0,"refs":[],"tier":"none_known"},"has_fix":null,"headline":"Missing authorization in n/a","id":"CVE-2011-3386","indexable":true,"kev":null,"kind":"cve","links":{"ecosystem":null,"product":null,"products":[],"type":"missing_authorization","year":"2011"},"n_packages":0,"n_references":8,"next":{"headline":"Denial of service in n/a","id":"CVE-2011-3387"},"packages":[],"prev":{"headline":"Cross-site scripting in n/a","id":"CVE-2011-3385"},"products":["n/a"],"published":"2011-09-02","related":[],"sources":[{"class":"attribution","licence":"CVE Terms of Use (MITRE)","name":"CVE List","prefix":"CVE"},{"class":"attribution","licence":"US public information, NVD API terms","name":"NVD"},{"class":"attribution","licence":"FIRST CVSS licence","name":"CVSS (FIRST)"}],"ssvc":{"automatable":null,"exploitation":null,"technical_impact":null},"state":"PUBLISHED","updated":"2024-08-06","vendors":["n/a"]},"summary":"Remote attackers can modify insulin delivery and cause denial of service via wireless communications using the device serial number.","url":"https://insights.sbomify.com/CVE-2011-3386/"}